ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

CVS vs RDGT // FREE CASH FLOW YIELD

CVS Health Corporation (NYSE) VS. Ridgetech Inc. (NASDAQ) • 15-METRIC TALLY: CVS 7 — RDGT 1
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CVS VS. RDGT) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC CVS RDGT SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 45.00% 3.60% +41.40 CVS /gross-margins <GO>
Return on Invested Capital (ROIC) 2.60% — — TIE /roic <GO>
EV/EBITDA & P/E Valuation 25.7x — — TIE /valuation <GO>
Free Cash Flow Yield ACTIVE 6.76% — — TIE /fcf-yield <GO>
Operating Margin 1.20% -1.40% +2.60 CVS /operating-margins <GO>
Net Profit Margin 0.40% -0.90% +1.30 CVS /net-margins <GO>
Revenue Growth (YoY) 7.80% 10.20% -2.40 RDGT /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 2.94% 0.00% +2.94 CVS /dividend-safety <GO>
Altman Z-Score & Debt/Equity 2.31 — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 7/9 1/9 +6.00 CVS /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 47.8 47.0 +0.80 CVS /rsi-technicals <GO>
10Y Yield & FRED Macro Beta 0.88 — — TIE /macro-sensitivity <GO>
Forward P/E Multiple 60.7x — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $115.53B $3.0M $115.53B CVS /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR CVS REV RDGT REV CVS GROSS % RDGT GROSS % CVS FCF RDGT FCF
FY 2025 $402.07B $132.2M 45.0% 3.6% $7.81B -$1.4M
FY 2024 $372.81B $120.0M 44.7% 3.2% $6.33B $1.1M
FY 2023 $357.78B $124.0M — — -$2.67B -$3.2M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CVS // BETA 0.88
RDGT // BETA —